Your browser doesn't support javascript.
loading
Behavioral Activation for Promoting Well-Being in Mild Dementia: Feasibility and Outcomes of a Pilot Randomized Controlled Trial.
Orgeta, Vasiliki; Tuijt, Remco; Leung, Phuong; Verdaguer, Elisabet Sole; Gould, Rebecca L; Jones, Rebecca; Livingston, Gill.
Afiliação
  • Orgeta V; University College London, London, UK.
  • Tuijt R; University College London, London, UK.
  • Leung P; University College London, London, UK.
  • Verdaguer ES; University College London, London, UK.
  • Gould RL; University College London, London, UK.
  • Jones R; University College London, London, UK.
  • Livingston G; University College London, London, UK.
J Alzheimers Dis ; 72(2): 563-574, 2019.
Article em En | MEDLINE | ID: mdl-31609689
ABSTRACT
Engaging in meaningful and enjoyable activities is an important contributor to well-being and maintaining good quality of life. There is a paucity of randomized controlled trials of interventions supporting people with mild dementia to engage in meaningful and purposeful activity. The aim of this study was to assess whether Behavioral Activation (BA) is an acceptable psychological intervention for people with mild dementia and whether a large-scale trial is feasible. Participants were randomly assigned to BA (n = 42) or treatment as usual (TAU) (n = 21). BA aimed at increasing engagement in enjoyable and meaningful activity, and preventing low mood. Follow-up was at 3 and 6 months. Assessors were blind to treatment allocation (trial registration number ISRCTN75503960). Retention rate was above 80% at both assessment time points. Treatment acceptability and credibility were high. Depressive symptoms remained unchanged in both groups. There was evidence of improvement associated with BA for every day function (-3.92, 95% Confidence Interval (CI) -6.87 to -0.97), and engagement in meaningful and enjoyable activity (5.08, 95% CI 0.99 to 9.16) post-treatment (3 months) in comparison to TAU. Both carer-rated patient health-related quality of life (0.16, 95% CI 0.04 to 0.28) and physical health (11.31, 95% CI 2.03 to 20.59) showed evidence of improvement at 3 months. Improvements in meaningful and enjoyable activity were maintained at 6 months.BA for people with mild dementia is feasible and acceptable and may be associated with clinically significant changes in function and quality of life. A full scale randomized controlled trial of clinical effectiveness is now needed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva Tipo de estudo: Clinical_trials / Etiology_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Assunto da revista: GERIATRIA / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disfunção Cognitiva Tipo de estudo: Clinical_trials / Etiology_studies Aspecto: Patient_preference Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Alzheimers Dis Assunto da revista: GERIATRIA / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido